XML 20 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss), Net of Income Tax
Retained Earnings
Common stock, issued, beginning balance (in shares) at Jun. 30, 2022   68,859,722        
Common stock, treasury, beginning balance (in shares) at Jun. 30, 2022     (9,081,773)      
Common stock, outstanding, beginning balance (in shares) at Jun. 30, 2022   59,777,949        
Stockholder's equity, beginning balance at Jun. 30, 2022 $ 1,642,973 $ 689 $ (237,011) $ 453,784 $ (2,933) $ 1,428,444
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 219,809         219,809
Other comprehensive income (loss) (2,640)       (2,640)  
Purchase of treasury stock (in shares)   (849,081) (849,081)      
Purchase of treasury stock (31,605)   $ (31,605)      
Stock-based compensation activity, issued (in shares)   480,811        
Stock-based compensation activity, treasury stock (in shares)     (54,555)      
Stock-based compensation activity, outstanding (in shares)   426,256        
Stock-based compensation activity 15,567 $ 5 $ (3,587) 19,149    
Common stock, issued, ending balance (in shares) at Mar. 31, 2023   69,340,533        
Common stock, treasury, ending balance (in shares) at Mar. 31, 2023     (9,985,409)      
Common stock, outstanding, ending balance (in shares) at Mar. 31, 2023   59,355,124        
Stockholder's equity, ending balance at Mar. 31, 2023 1,844,104 $ 694 $ (272,203) 472,933 (5,573) 1,648,253
Common stock, issued, beginning balance (in shares) at Dec. 31, 2022   69,153,591        
Common stock, treasury, beginning balance (in shares) at Dec. 31, 2022     (9,153,512)      
Common stock, outstanding, beginning balance (in shares) at Dec. 31, 2022   60,000,079        
Stockholder's equity, beginning balance at Dec. 31, 2022 1,787,559 $ 692 $ (239,941) 465,350 (6,945) 1,568,403
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 79,850         79,850
Other comprehensive income (loss) 1,372       1,372  
Purchase of treasury stock (in shares)   (849,081) (849,081)      
Purchase of treasury stock (31,605)   $ (31,605)      
Stock-based compensation activity, issued (in shares)   186,942        
Stock-based compensation activity, treasury stock (in shares)     17,184      
Stock-based compensation activity, outstanding (in shares)   204,126        
Stock-based compensation activity 6,928 $ 2 $ (657) 7,583    
Common stock, issued, ending balance (in shares) at Mar. 31, 2023   69,340,533        
Common stock, treasury, ending balance (in shares) at Mar. 31, 2023     (9,985,409)      
Common stock, outstanding, ending balance (in shares) at Mar. 31, 2023   59,355,124        
Stockholder's equity, ending balance at Mar. 31, 2023 $ 1,844,104 $ 694 $ (272,203) 472,933 (5,573) 1,648,253
Common stock, issued, beginning balance (in shares) at Jun. 30, 2023 69,465,446 69,465,446        
Common stock, treasury, beginning balance (in shares) at Jun. 30, 2023 (10,522,411)   (10,522,411)      
Common stock, outstanding, beginning balance (in shares) at Jun. 30, 2023 58,943,035 58,943,035        
Stockholder's equity, beginning balance at Jun. 30, 2023 $ 1,917,159 $ 695 $ (292,413) 479,878 (6,610) 1,735,609
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 345,136         345,136
Other comprehensive income (loss) 3,546       3,546  
Purchase of treasury stock (in shares)   (2,267,610) (2,267,610)      
Purchase of treasury stock (83,781)   $ (83,781)      
Stock-based compensation activity, issued (in shares)   568,077        
Stock-based compensation activity, treasury stock (in shares)     (164,073)      
Stock-based compensation activity, outstanding (in shares)   404,004        
Stock-based compensation activity $ 14,233 $ 5 $ (8,383) 22,611    
Common stock, issued, ending balance (in shares) at Mar. 31, 2024 70,033,523 70,033,523        
Common stock, treasury, ending balance (in shares) at Mar. 31, 2024 (12,954,094)   (12,954,094)      
Common stock, outstanding, ending balance (in shares) at Mar. 31, 2024 57,079,429 57,079,429        
Stockholder's equity, ending balance at Mar. 31, 2024 $ 2,196,293 $ 700 $ (384,577) 502,489 (3,064) 2,080,745
Common stock, issued, beginning balance (in shares) at Dec. 31, 2023   69,828,709        
Common stock, treasury, beginning balance (in shares) at Dec. 31, 2023     (12,930,332)      
Common stock, outstanding, beginning balance (in shares) at Dec. 31, 2023   56,898,377        
Stockholder's equity, beginning balance at Dec. 31, 2023 2,078,224 $ 698 $ (381,848) 493,268 (3,919) 1,970,025
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 110,720         110,720
Other comprehensive income (loss) 855       855  
Purchase of treasury stock (in shares)   (12,101) (12,101)      
Purchase of treasury stock (595)   $ (595)      
Stock-based compensation activity, issued (in shares)   204,814        
Stock-based compensation activity, treasury stock (in shares)     (11,661)      
Stock-based compensation activity, outstanding (in shares)   193,153        
Stock-based compensation activity $ 7,089 $ 2 $ (2,134) 9,221    
Common stock, issued, ending balance (in shares) at Mar. 31, 2024 70,033,523 70,033,523        
Common stock, treasury, ending balance (in shares) at Mar. 31, 2024 (12,954,094)   (12,954,094)      
Common stock, outstanding, ending balance (in shares) at Mar. 31, 2024 57,079,429 57,079,429        
Stockholder's equity, ending balance at Mar. 31, 2024 $ 2,196,293 $ 700 $ (384,577) $ 502,489 $ (3,064) $ 2,080,745